SCHEMBL7308372

SCHEMBL7308372

Cc1ccccc1N1CCN(C(=O)CCCn2c(=O)[nH]c(=O)c3ccccc32)CC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.57
LMNA P02545 5/20 0.57
USP2 O75604 3/20 0.57
NPSR1 Q6W5P4 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
TSHR P16473 2/20 0.57
ALOX15 P16050 1/20 0.57
MAPT P10636 10/20 0.56
TP53 P04637 4/20 0.56
HSD17B10 Q99714 1/20 0.51
ESR1 P03372 2/20 0.51
HTR1A P08908 1/20 0.51
DRD2 P14416 1/20 0.51
HTR2A P28223 1/20 0.51
ALDH1A1 P00352 1/20 0.48
ADAMTS5 Q9UNA0 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301705 0.86 LMNA (0.61) LMNAUSP2NPSR1MAPTHSD17B10
SCHEMBL7302783 0.85 MAPT (0.70) LMNAUSP2NPSR1SMN1; SMN2TSHR
SCHEMBL7303413 0.85 MAPT (0.49) LMNAUSP2NPSR1SMN1; SMN2TSHR
SCHEMBL7297796 0.84 HTR1A (0.68) HTR1ADRD2HTR2A
SCHEMBL7306335 0.76 HSD17B10 (0.56) LMNAUSP2NPSR1SMN1; SMN2TSHR
SCHEMBL7300140 0.74 FABP4 (0.68) TSHRHSD17B10HTR1ADRD2HTR2A
SCHEMBL14871799 0.73 AR (1.00) ARLMNANPSR1SMN1; SMN2TSHR
SCHEMBL4075010 0.73 AR (0.76) ARLMNAUSP2NPSR1SMN1; SMN2
SCHEMBL15224127 0.73 AR (0.72) ARLMNANPSR1SMN1; SMN2TSHR
SCHEMBL7308089 0.73 TNF (0.62) LMNAMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed